Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00723
Species: Homo sapiens
Position : chr4:15581130-15619993
Year: 2021
Title: H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: B-cell acute lymphoblastic leukemia
PMID:  32242051
MONDO: MONDO:0004945
Tissue: Bone Marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: Primary MLL-AF4 ALL blasts
CVCL ID:
Cell Type: B lymphoblast
Cell Ontology ID: CL:0000945
Experiment Type: Enhancer activity assay, Chromatin interaction assay, TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq, ATAC-seq, Capture-C, RNA-seq
Low Throughput Method: ChIP-RT-qPCR, RT-RT-qPCR, Western blot
About Target Gene
Target gene : TAPT1
About TF
TF name :
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 6 found
Enhancer ID Position Tissue Cell Disease
E_00721 chr4:15581130-15619993 Bone Marrow B lymphoblast acute lymphoblastic leukemia
E_00722 chr4:15581130-15619993 Colon colorectal carcinoma cell colorectal carcinoma
E_01081 chr4:15581130-15619993 Embryonic Kidney embryonic kidney cell --
E_01082 chr4:15581130-15619993 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
E_01083 chr4:15581130-15619993 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
E_01084 chr4:15581130-15619993 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer